尽管战争在英国仍存在药物短缺问题, 但运输成本上升威胁到仿制药的可负担性和供应. UK avoids drug shortages despite war, but rising freight costs threaten generic drug affordability and supply.

尽管中东战争, 英国仍避免药物短缺, 但随着运费的上, 一般制药商的利受到了压力. Britain has avoided medicine shortages despite the Middle East war, but rising freight costs are straining generic drugmakers' profits, warns Medicines UK. 首席执行官马克·萨尔斯表示,财政压力可能导致价格上升或短缺,特别是低利率的仿制药和生物类似药. Chief Executive Mark Samuels says financial pressure could lead to higher prices or shortages, especially for low-margin generics and biosimilars. 虽然供应链仍完好无损,但持续的航运中断威胁着长期可负担性和可用性,促使人们呼吁紧急监测以防止未来危机. While supply chains remain intact, ongoing shipping disruptions threaten long-term affordability and availability, prompting calls for urgent monitoring to prevent future crises.